These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 23216129)

  • 1. Hepatopathy-thrombocytopenia syndrome after actinomycin-D therapy: treatment with defibrotide.
    Martín-Lázaro JF; Palanca D; Garcia-Iñiguez JP; Madurga P; Carboné A
    Pediatr Hematol Oncol; 2013 Feb; 30(1):25-7. PubMed ID: 23216129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatopathy-thrombocytopenia syndrome (HTS) after actinomycin-D therapy: report of three cases and review of the literature.
    Farruggia P; Macaluso A; Tropia S; Di Marco F; Russo D; Grigoli A; Trizzino A; D'Angelo P
    Pediatr Hematol Oncol; 2011 Apr; 28(3):237-43. PubMed ID: 21271778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatopathy-thrombocytopenia syndrome--a complication of dactinomycin therapy for Wilms' tumor: a report from the United Kingdom Childrens Cancer Study Group.
    Raine J; Bowman A; Wallendszus K; Pritchard J
    J Clin Oncol; 1991 Feb; 9(2):268-73. PubMed ID: 1846405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatopathy-Thrombocytopenia Syndrome During Actinomycin D Treatment May Be Related to MDR1 (ABCB1) Gene Polymorphisms.
    Baskin Y; Amirfallah A; Calibasi G; Olgun N
    Am J Ther; 2016; 23(2):e594-6. PubMed ID: 24413370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic veno-occlusive disease during chemotherapy for nephroblastoma: successful and safe treatment with defibrotide. Report of a clinical case.
    Cecinati V; Giordano P; De Leonardis F; Grassi M; Arcamone G; De Mattia D; Santoro N
    Immunopharmacol Immunotoxicol; 2009; 31(4):702-5. PubMed ID: 19874245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatotoxicity of chemotherapy following nephrectomy and radiation therapy for right-sided Wilms tumor.
    McVeagh P; Ekert H
    J Pediatr; 1975 Oct; 87(4):627-8. PubMed ID: 169340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective thrombocytopenia in children with Wilms tumor: an immune-mediated effect of dactinomycin?
    Shannon A; Smith J; Nagel K; Levesque R; Warkentin T; Barr R
    Med Pediatr Oncol; 2003 Nov; 41(5):483-5. PubMed ID: 14515398
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune thrombocytopenia following actinomycin-D therapy.
    Hodder FS; Kempert P; McCormack S; Bennetts GA; Katz J; Cairo MS
    J Pediatr; 1985 Oct; 107(4):611-4. PubMed ID: 2995631
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatotoxicity of actinomycin-D.
    Pritchard J; Raine J; Wallendszus K
    Lancet; 1989 Jan; 1(8630):168. PubMed ID: 2563091
    [No Abstract]   [Full Text] [Related]  

  • 10. Wilms' tumour: adjuvant treatment with actinomycin D and vincristine.
    Jenkin RD; Jeffs RD; Stephens CA; Sonley MJ
    Can Med Assoc J; 1976 Jul; 115(2):136-40. PubMed ID: 179690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatotoxicity and actinomycin D.
    Lancet; 1990 May; 335(8700):1290. PubMed ID: 1971368
    [No Abstract]   [Full Text] [Related]  

  • 12. Sinusoidal Obstruction Syndrome During Chemotherapy of Pediatric Cancers and its Successful Management With Defibrotide.
    Kizilocak H; Dikme G; Özdemir N; Kuruğoğlu S; Adaletli İ; Erkan T; Celkan T
    J Pediatr Hematol Oncol; 2017 Oct; 39(7):e373-e376. PubMed ID: 28859028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Veno-occlusive disease of the liver and nephroblastoma in children (role of the vincristine-actinomycin combination?].
    Chevallier B; Treluyer JM; Devictor D; Yaiche MC; Lagardère B
    Ann Pediatr (Paris); 1988 Sep; 35(7):525-6. PubMed ID: 2460015
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatotoxicity with actinomycin D.
    D'Angio GJ
    Lancet; 1987 Jul; 2(8550):104. PubMed ID: 2885556
    [No Abstract]   [Full Text] [Related]  

  • 15. A report of an actinomycin D study group in Japan.
    Takatsu T
    Paediatr Univ Tokyo; 1970 Jan; 17():7-9. PubMed ID: 4315852
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatopathy-thrombocytopenia vs infection-induced hemophagocytic syndrome in Wilms' tumor: a case report.
    Hathirat P; Numhom S; Chuansumrit A; Chantarojanasiri T; Sirinavin S; Isarangkura P
    J Med Assoc Thai; 1993 Oct; 76 Suppl 2():240-3. PubMed ID: 7823002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of the Wilms' tumor with actinomycin D.
    Sipahi ML
    Turk J Pediatr; 1969 Jul; 11(3):98-105. PubMed ID: 4313305
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatotoxicity of chemotherapy following nephrectomy and radiation therapy for right-sided Wilms tumor.
    Jayabose S; Shende A; Lanzkowsky P
    J Pediatr; 1976 May; 88(5):898. PubMed ID: 178848
    [No Abstract]   [Full Text] [Related]  

  • 19. [Veno-occlusive disease of the liver as a treatment complication in children with Wilm's tumor].
    Zoubek A; Wiesbauer P; Pracher E; Martins da Cunha AC; Emminger W; Grois N; Gadner H
    Padiatr Padol; 1992; 27(2):47-50. PubMed ID: 1318536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actinomycin D in management of Wilms' tumor.
    Fernbach DJ; Sukarochana K; Kiesewetter WB
    J Pediatr; 1967 May; 70(5):860-2. PubMed ID: 4164457
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.